Early detection of lung cancer

Most patients with lung cancer are diagnosed when they present with symptoms, they have advanced stage disease, and curative treatment is no longer an option. An effective screening test has long been desired for early detection with the goal of reducing mortality from lung cancer. Sputum cytology, chest radiography, and computed tomography (CT) scan have been studied as potential screening tests. The National Lung Screening Trial (NLST) demonstrated a 20% reduction in mortality with low-dose CT (LDCT) screening, and guidelines now endorse annual LDCT for those at high risk. Implementation of screening is underway with the desire that the benefits be seen in clinical practice outside of a research study format. Concerns include management of false positives, cost, incidental findings, radiation exposure, and overdiagnosis. Studies continue to evaluate LDCT screening and use of biomarkers in risk assessment and diagnosis in attempt to further improve outcomes for patients with lung cancer.

[1]  G. Veronesi Lung cancer screening: the European perspective. , 2015, Thoracic surgery clinics.

[2]  W. Heindel,et al.  Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers , 2004, European Radiology.

[3]  Young-Jun Jeon,et al.  MicroRNAs in lung cancer. , 2014, World journal of methodology.

[4]  D. Naidich,et al.  Screening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[5]  Y. Miller,et al.  Validation of a Multiprotein Plasma Classifier to Identify Benign Lung Nodules , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Yiding Jiang,et al.  An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. , 2012, Health affairs.

[7]  C. la Vecchia,et al.  Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[9]  Diederick E Grobbee,et al.  Prevalence of Incidental Findings in Computed Tomographic Screening of the Chest: A Systematic Review , 2008, Journal of computer assisted tomography.

[10]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[11]  R. Wiener Low-Dose Computed Tomography Screening for Lung Cancer , 2015, Annals of Internal Medicine.

[12]  J. Jett,et al.  udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice , 2014 .

[13]  M. Scorsetti,et al.  Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. , 2015, American journal of respiratory and critical care medicine.

[14]  E. Bergstralh,et al.  Screening for lung cancer. A critique of the mayo lung project , 1991, Cancer.

[15]  Asger Dirksen,et al.  Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. , 2016, American journal of respiratory and critical care medicine.

[16]  Massimo Bellomi,et al.  Lung Cancer Risk Prediction to Select Smokers for Screening CT—a Model Based on the Italian COSMOS Trial , 2011, Cancer Prevention Research.

[17]  L. Cardinale,et al.  Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. , 2013, Clinical lung cancer.

[18]  P. Lee,et al.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer , 2012, BMC Cancer.

[19]  S. Lam,et al.  Probability of cancer in pulmonary nodules detected on first screening CT. , 2013, The New England journal of medicine.

[20]  J. Jett,et al.  Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. , 2015, Chest.

[21]  G. Silvestri,et al.  A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. , 2015, The New England journal of medicine.

[22]  M. L. R. D. Christenson,et al.  Five-year Lung Cancer Screening Experience: CT Appearance, Growth Rate, Location, and Histologic Features of 61 Lung Cancers , 2008 .

[23]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[24]  S. Ramsey,et al.  Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare. , 2015, Journal of oncology practice.

[25]  Harry J de Koning,et al.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. , 2014, The Lancet. Oncology.

[26]  Natalie N. Braun,et al.  Strategies for reducing radiation dose in CT. , 2009, Radiologic clinics of North America.

[27]  Massimo Bellomi,et al.  miR-Test: a blood test for lung cancer early detection. , 2015, Journal of the National Cancer Institute.

[28]  Fenghai Duan,et al.  Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. , 2014, Journal of the National Cancer Institute.

[29]  Edward J Diamond,et al.  An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. , 2014, Chest.

[30]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[31]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[32]  S. Swensen,et al.  Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. , 2004, The Journal of thoracic and cardiovascular surgery.

[33]  A. Richardson Screening and the number needed to treat , 2001, Journal of medical screening.

[34]  Lisa M. Schwartz,et al.  What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. , 2013, Chest.

[35]  Arash Naeim,et al.  Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.

[36]  Antoine Flahault,et al.  Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). , 2007, Lung cancer.

[37]  W. Heindel,et al.  Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. , 2002, Radiology.

[38]  Michael F. McNitt-Gray,et al.  ACR–STR Practice Parameter for the Performance and Reporting of Lung Cancer Screening Thoracic Computed Tomography (CT): 2014 (Resolution 4)* , 2014, Journal of thoracic imaging.

[39]  Ahmedin Jemal,et al.  Annual number of lung cancer deaths potentially avertable by screening in the United States , 2013, Cancer.

[40]  J. Mulshine,et al.  Issues with implementing a high‐quality lung cancer screening program , 2014, CA: a cancer journal for clinicians.

[41]  M. Oudkerk,et al.  Neglectable benefit of searching for incidental findings in the Dutch--Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT , 2007, European Radiology.

[42]  Massimo Bellomi,et al.  Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[44]  Maureen A Smith,et al.  Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.

[45]  H. D. de Koning,et al.  Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON) , 2009, British Journal of Cancer.

[46]  R. Elosua,et al.  [Trends in the proportion of patients younger than 75 years with acute myocardial infarction and Killip class III and IV. variables associated with occurence and case-fatality: 1978-1997]. , 2002, Revista espanola de cardiologia.

[47]  B. Kramer,et al.  Overdiagnosis in low-dose computed tomography screening for lung cancer. , 2014, JAMA internal medicine.

[48]  V. Moyer Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[49]  N J Wald,et al.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening , 2015, Thorax.

[50]  D. Midthun,et al.  Trends in the proportion of patients with lung cancer meeting screening criteria. , 2015, Journal of the American Medical Association (JAMA).

[51]  H Nakata,et al.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. , 2000, AJR. American journal of roentgenology.

[52]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[53]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[54]  U. Ladabaum,et al.  Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies , 2013, The American Journal of Gastroenterology.

[55]  Yi Wang,et al.  Trends in Subpopulations at High Risk for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[56]  F. Petrella,et al.  Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. , 2013, Lung cancer.

[57]  Matthew B Schabath,et al.  Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[58]  M. Mascalchi,et al.  Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[59]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[60]  Ugo Pastorino,et al.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[61]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[62]  Peter Balter,et al.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. , 2015, The Lancet. Oncology.

[63]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[64]  C. Berg,et al.  Targeting of low-dose CT screening according to the risk of lung-cancer death. , 2013, The New England journal of medicine.

[65]  D. Midthun,et al.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. , 2015, American journal of respiratory and critical care medicine.

[66]  D. Naidich,et al.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.